WAT · Waters Corp /De/ · Debt

(a) The Company hereby establishes five series of Securities designated the “4.321% Senior Notes due 2027,” the “4.398% Senior Notes due 2029,” the “4.656% Senior Notes due 2031,” the “4.945% Senior Notes due 2033” and the “5.245% Senior Notes due 2036,” respectively, for issuance under the Indenture. Each series of Notes may be authenticated and delivered under the Indenture in an unlimited aggregate principal amount. The 2027 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $650,000,000. The 2029 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $600,000,000. The 2031 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2033 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2036 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The Notes are unsecured and shall rank equally with the Company’s other unsecured and unsubordinated Indebtedness.

Issuer evidence: **FIRST SUPPLEMENTAL INDENTURE**, dated as of March 23, 2026 (this “First Supplemental Indenture”), among Augusta SpinCo Corporation, a Delaware corporation, as issuer (the “Company”), Waters Corporation, a Delaware corporation (the “Parent Guarantor”), Waters Technologies Corporation, a Delaware corporation (“WTC”), TA Instruments – Waters L.L.C., a Delaware limited liability company (“TA”), Waters Asia Limited, a Delaware corporation (“Waters Asia”), Wyatt Technology, LLC, a California limited liability company (“Wyatt”), Accuri Cytometers, Inc., a Delaware corporation (“Accuri”), Augusta Life Sciences US OpCo I LLC, a Delaware limited liability company (“ALS OpCo I”), Augusta Life Sciences US OpCo II LLC, a Delaware limited liability company (“ALS OpCo II”), Augusta Life Sciences US SpinCo LLC, a Delaware limited liability company (“ALS SpinCo”), Cellular Research, Inc., a Delaware corporation (“Cellular”), HandyLab, Inc., a Delaware corporation (“HandyLab”), and PharMingen, a California corporation (“PharMingen” and collectively with WTC, TA, Waters Asia, Wyatt, Accuri, ALS OpCo I, ALS OpCo II, ALS SpinCo, Cellular and HandyLab, the “Subsidiary Guarantors” and each individually, a “Subsidiary Guarantor”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to the Base Indenture (as defined below).

Supporting evidence: 2.02 Maturity. Unless an earlier redemption has occurred, the principal amount of the 2027 Notes shall mature and be due and payable on September 23, 2027 (the “2027 Notes Maturity Date”), the principal amount of the 2029 Notes shall mature and be due and payable on March 23, 2029 (the “2029 Notes Maturity Date”), the principal amount of the 2031 Notes shall mature and be due and payable on March 23, 2031 (the “2031 Notes Maturity Date”), the principal amount of the 2033 Notes shall mature and be due and payable on March 23, 2033 (the “2033 Notes Maturity Date”) and the principal amount of the 2036 Notes shall mature and be due and payable on March 23, 2036 (the “2036 Notes Maturity Date” and collectively with the 2027 Notes Maturity Date, the 2029 Notes Maturity Date, the 2031 Notes Maturity Date and the 2033 Notes Maturity Date, the “Maturity Dates” and each individually, a “Maturity Date”).

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

(a) The Company hereby establishes five series of Securities designated the “4.321% Senior Notes due 2027,” the “4.398% Senior Notes due 2029,” the “4.656% Senior Notes due 2031,” the “4.945% Senior Notes due 2033” and the “5.245% Senior Notes due 2036,” respectively, for issuance under the Indenture. Each series of Notes may be authenticated and delivered under the Indenture in an unlimited aggregate principal amount. The 2027 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $650,000,000. The 2029 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $600,000,000. The 2031 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2033 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2036 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The Notes are unsecured and shall rank equally with the Company’s other unsecured and unsubordinated Indebtedness.

Issuer evidence: **FIRST SUPPLEMENTAL INDENTURE**, dated as of March 23, 2026 (this “First Supplemental Indenture”), among Augusta SpinCo Corporation, a Delaware corporation, as issuer (the “Company”), Waters Corporation, a Delaware corporation (the “Parent Guarantor”), Waters Technologies Corporation, a Delaware corporation (“WTC”), TA Instruments – Waters L.L.C., a Delaware limited liability company (“TA”), Waters Asia Limited, a Delaware corporation (“Waters Asia”), Wyatt Technology, LLC, a California limited liability company (“Wyatt”), Accuri Cytometers, Inc., a Delaware corporation (“Accuri”), Augusta Life Sciences US OpCo I LLC, a Delaware limited liability company (“ALS OpCo I”), Augusta Life Sciences US OpCo II LLC, a Delaware limited liability company (“ALS OpCo II”), Augusta Life Sciences US SpinCo LLC, a Delaware limited liability company (“ALS SpinCo”), Cellular Research, Inc., a Delaware corporation (“Cellular”), HandyLab, Inc., a Delaware corporation (“HandyLab”), and PharMingen, a California corporation (“PharMingen” and collectively with WTC, TA, Waters Asia, Wyatt, Accuri, ALS OpCo I, ALS OpCo II, ALS SpinCo, Cellular and HandyLab, the “Subsidiary Guarantors” and each individually, a “Subsidiary Guarantor”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to the Base Indenture (as defined below).

Supporting evidence: 2.02 Maturity. Unless an earlier redemption has occurred, the principal amount of the 2027 Notes shall mature and be due and payable on September 23, 2027 (the “2027 Notes Maturity Date”), the principal amount of the 2029 Notes shall mature and be due and payable on March 23, 2029 (the “2029 Notes Maturity Date”), the principal amount of the 2031 Notes shall mature and be due and payable on March 23, 2031 (the “2031 Notes Maturity Date”), the principal amount of the 2033 Notes shall mature and be due and payable on March 23, 2033 (the “2033 Notes Maturity Date”) and the principal amount of the 2036 Notes shall mature and be due and payable on March 23, 2036 (the “2036 Notes Maturity Date” and collectively with the 2027 Notes Maturity Date, the 2029 Notes Maturity Date, the 2031 Notes Maturity Date and the 2033 Notes Maturity Date, the “Maturity Dates” and each individually, a “Maturity Date”).

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

(a) The Company hereby establishes five series of Securities designated the “4.321% Senior Notes due 2027,” the “4.398% Senior Notes due 2029,” the “4.656% Senior Notes due 2031,” the “4.945% Senior Notes due 2033” and the “5.245% Senior Notes due 2036,” respectively, for issuance under the Indenture. Each series of Notes may be authenticated and delivered under the Indenture in an unlimited aggregate principal amount. The 2027 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $650,000,000. The 2029 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $600,000,000. The 2031 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2033 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2036 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The Notes are unsecured and shall rank equally with the Company’s other unsecured and unsubordinated Indebtedness.

Issuer evidence: **FIRST SUPPLEMENTAL INDENTURE**, dated as of March 23, 2026 (this “First Supplemental Indenture”), among Augusta SpinCo Corporation, a Delaware corporation, as issuer (the “Company”), Waters Corporation, a Delaware corporation (the “Parent Guarantor”), Waters Technologies Corporation, a Delaware corporation (“WTC”), TA Instruments – Waters L.L.C., a Delaware limited liability company (“TA”), Waters Asia Limited, a Delaware corporation (“Waters Asia”), Wyatt Technology, LLC, a California limited liability company (“Wyatt”), Accuri Cytometers, Inc., a Delaware corporation (“Accuri”), Augusta Life Sciences US OpCo I LLC, a Delaware limited liability company (“ALS OpCo I”), Augusta Life Sciences US OpCo II LLC, a Delaware limited liability company (“ALS OpCo II”), Augusta Life Sciences US SpinCo LLC, a Delaware limited liability company (“ALS SpinCo”), Cellular Research, Inc., a Delaware corporation (“Cellular”), HandyLab, Inc., a Delaware corporation (“HandyLab”), and PharMingen, a California corporation (“PharMingen” and collectively with WTC, TA, Waters Asia, Wyatt, Accuri, ALS OpCo I, ALS OpCo II, ALS SpinCo, Cellular and HandyLab, the “Subsidiary Guarantors” and each individually, a “Subsidiary Guarantor”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to the Base Indenture (as defined below).

Supporting evidence: 2.02 Maturity. Unless an earlier redemption has occurred, the principal amount of the 2027 Notes shall mature and be due and payable on September 23, 2027 (the “2027 Notes Maturity Date”), the principal amount of the 2029 Notes shall mature and be due and payable on March 23, 2029 (the “2029 Notes Maturity Date”), the principal amount of the 2031 Notes shall mature and be due and payable on March 23, 2031 (the “2031 Notes Maturity Date”), the principal amount of the 2033 Notes shall mature and be due and payable on March 23, 2033 (the “2033 Notes Maturity Date”) and the principal amount of the 2036 Notes shall mature and be due and payable on March 23, 2036 (the “2036 Notes Maturity Date” and collectively with the 2027 Notes Maturity Date, the 2029 Notes Maturity Date, the 2031 Notes Maturity Date and the 2033 Notes Maturity Date, the “Maturity Dates” and each individually, a “Maturity Date”).

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

(a) The Company hereby establishes five series of Securities designated the “4.321% Senior Notes due 2027,” the “4.398% Senior Notes due 2029,” the “4.656% Senior Notes due 2031,” the “4.945% Senior Notes due 2033” and the “5.245% Senior Notes due 2036,” respectively, for issuance under the Indenture. Each series of Notes may be authenticated and delivered under the Indenture in an unlimited aggregate principal amount. The 2027 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $650,000,000. The 2029 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $600,000,000. The 2031 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2033 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2036 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The Notes are unsecured and shall rank equally with the Company’s other unsecured and unsubordinated Indebtedness.

Issuer evidence: **FIRST SUPPLEMENTAL INDENTURE**, dated as of March 23, 2026 (this “First Supplemental Indenture”), among Augusta SpinCo Corporation, a Delaware corporation, as issuer (the “Company”), Waters Corporation, a Delaware corporation (the “Parent Guarantor”), Waters Technologies Corporation, a Delaware corporation (“WTC”), TA Instruments – Waters L.L.C., a Delaware limited liability company (“TA”), Waters Asia Limited, a Delaware corporation (“Waters Asia”), Wyatt Technology, LLC, a California limited liability company (“Wyatt”), Accuri Cytometers, Inc., a Delaware corporation (“Accuri”), Augusta Life Sciences US OpCo I LLC, a Delaware limited liability company (“ALS OpCo I”), Augusta Life Sciences US OpCo II LLC, a Delaware limited liability company (“ALS OpCo II”), Augusta Life Sciences US SpinCo LLC, a Delaware limited liability company (“ALS SpinCo”), Cellular Research, Inc., a Delaware corporation (“Cellular”), HandyLab, Inc., a Delaware corporation (“HandyLab”), and PharMingen, a California corporation (“PharMingen” and collectively with WTC, TA, Waters Asia, Wyatt, Accuri, ALS OpCo I, ALS OpCo II, ALS SpinCo, Cellular and HandyLab, the “Subsidiary Guarantors” and each individually, a “Subsidiary Guarantor”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to the Base Indenture (as defined below).

Supporting evidence: 2.02 Maturity. Unless an earlier redemption has occurred, the principal amount of the 2027 Notes shall mature and be due and payable on September 23, 2027 (the “2027 Notes Maturity Date”), the principal amount of the 2029 Notes shall mature and be due and payable on March 23, 2029 (the “2029 Notes Maturity Date”), the principal amount of the 2031 Notes shall mature and be due and payable on March 23, 2031 (the “2031 Notes Maturity Date”), the principal amount of the 2033 Notes shall mature and be due and payable on March 23, 2033 (the “2033 Notes Maturity Date”) and the principal amount of the 2036 Notes shall mature and be due and payable on March 23, 2036 (the “2036 Notes Maturity Date” and collectively with the 2027 Notes Maturity Date, the 2029 Notes Maturity Date, the 2031 Notes Maturity Date and the 2033 Notes Maturity Date, the “Maturity Dates” and each individually, a “Maturity Date”).

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

(a) The Company hereby establishes five series of Securities designated the “4.321% Senior Notes due 2027,” the “4.398% Senior Notes due 2029,” the “4.656% Senior Notes due 2031,” the “4.945% Senior Notes due 2033” and the “5.245% Senior Notes due 2036,” respectively, for issuance under the Indenture. Each series of Notes may be authenticated and delivered under the Indenture in an unlimited aggregate principal amount. The 2027 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $650,000,000. The 2029 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $600,000,000. The 2031 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2033 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The 2036 Notes issued on the date hereof pursuant to the terms of the Indenture shall be in an initial aggregate principal amount of $750,000,000. The Notes are unsecured and shall rank equally with the Company’s other unsecured and unsubordinated Indebtedness.

Issuer evidence: **FIRST SUPPLEMENTAL INDENTURE**, dated as of March 23, 2026 (this “First Supplemental Indenture”), among Augusta SpinCo Corporation, a Delaware corporation, as issuer (the “Company”), Waters Corporation, a Delaware corporation (the “Parent Guarantor”), Waters Technologies Corporation, a Delaware corporation (“WTC”), TA Instruments – Waters L.L.C., a Delaware limited liability company (“TA”), Waters Asia Limited, a Delaware corporation (“Waters Asia”), Wyatt Technology, LLC, a California limited liability company (“Wyatt”), Accuri Cytometers, Inc., a Delaware corporation (“Accuri”), Augusta Life Sciences US OpCo I LLC, a Delaware limited liability company (“ALS OpCo I”), Augusta Life Sciences US OpCo II LLC, a Delaware limited liability company (“ALS OpCo II”), Augusta Life Sciences US SpinCo LLC, a Delaware limited liability company (“ALS SpinCo”), Cellular Research, Inc., a Delaware corporation (“Cellular”), HandyLab, Inc., a Delaware corporation (“HandyLab”), and PharMingen, a California corporation (“PharMingen” and collectively with WTC, TA, Waters Asia, Wyatt, Accuri, ALS OpCo I, ALS OpCo II, ALS SpinCo, Cellular and HandyLab, the “Subsidiary Guarantors” and each individually, a “Subsidiary Guarantor”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to the Base Indenture (as defined below).

Supporting evidence: 2.02 Maturity. Unless an earlier redemption has occurred, the principal amount of the 2027 Notes shall mature and be due and payable on September 23, 2027 (the “2027 Notes Maturity Date”), the principal amount of the 2029 Notes shall mature and be due and payable on March 23, 2029 (the “2029 Notes Maturity Date”), the principal amount of the 2031 Notes shall mature and be due and payable on March 23, 2031 (the “2031 Notes Maturity Date”), the principal amount of the 2033 Notes shall mature and be due and payable on March 23, 2033 (the “2033 Notes Maturity Date”) and the principal amount of the 2036 Notes shall mature and be due and payable on March 23, 2036 (the “2036 Notes Maturity Date” and collectively with the 2027 Notes Maturity Date, the 2029 Notes Maturity Date, the 2031 Notes Maturity Date and the 2033 Notes Maturity Date, the “Maturity Dates” and each individually, a “Maturity Date”).

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

Supporting evidence: **WHEREAS**, pursuant to the terms of the Base Indenture, on the date hereof, the Company desires to provide for the establishment of five new series of notes to be known as its 4.321% Senior Notes due 2027 (the “2027 Notes”), 4.398% Senior Notes due 2029 (the “2029 Notes”), 4.656% Senior Notes due 2031 (the “2031 Notes”), 4.945% Senior Notes due 2033 (the “2033 Notes”) and 5.245% Senior Notes due 2036 (the “2036 Notes” and collectively with the 2027 Notes, the 2029 Notes, the 2031 Notes and the 2033 Notes, the “Notes”), the form and substance of the Notes and the terms, provisions and conditions thereof to be set forth as provided in the Base Indenture and herein;

On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Issuer evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Supporting evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Supporting evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Issuer evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Supporting evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Issuer evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Supporting evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Issuer evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Supporting evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Issuer evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).

Supporting evidence: On March 23, 2026, Augusta SpinCo Corporation (the “Issuer”), a subsidiary of Waters Corporation (the “Company”), completed the public offering (the “Offering”) of $3.5 billion aggregate principal amount of senior notes, consisting of (i) $650 million aggregate principal amount of 4.321% Senior Notes due 2027 (the “2027 Notes”), (ii) $600 million aggregate principal amount of 4.398% Senior Notes due 2029, (iii) $750 million aggregate principal amount of 4.656% Senior Notes due 2031, (iv) $750 million aggregate principal amount of 4.945% Senior Notes due 2033 and (v) $750 million aggregate principal amount of 5.245% Senior Notes due 2036 (collectively, the “Notes”). The obligations of the Issuer under the Notes are fully and unconditionally guaranteed on a senior unsecured basis (the “Guarantees”) by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities (the “Subsidiary Guarantors” and, together with the Company, the “Guarantors”).